216 related articles for article (PubMed ID: 35357810)
1. Sequential Ultrasound-Triggered and Hypoxia-Sensitive Nanoprodrug for Cascade Amplification of Sonochemotherapy.
Zhuang F; Ma Q; Dong C; Xiang H; Shen Y; Sun P; Li C; Chen Y; Lu B; Chen Y; Huang B
ACS Nano; 2022 Apr; 16(4):5439-5453. PubMed ID: 35357810
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-Adapted Sono-chemodynamic Treatment of Orthotopic Pancreatic Carcinoma Using Copper Metal-Organic Frameworks Loaded with an Ultrasound-Induced Free Radical Initiator.
Sun Y; Cao J; Wang X; Zhang C; Luo J; Zeng Y; Zhang C; Li Q; Zhang Y; Xu W; Zhang T; Huang P
ACS Appl Mater Interfaces; 2021 Aug; 13(32):38114-38126. PubMed ID: 34357760
[TBL] [Abstract][Full Text] [Related]
3. Sono-Controllable and ROS-Sensitive CRISPR-Cas9 Genome Editing for Augmented/Synergistic Ultrasound Tumor Nanotherapy.
Pu Y; Yin H; Dong C; Xiang H; Wu W; Zhou B; Du D; Chen Y; Xu H
Adv Mater; 2021 Nov; 33(45):e2104641. PubMed ID: 34536041
[TBL] [Abstract][Full Text] [Related]
4. ROS-Responsive Blended Nanoparticles: Cascade-Amplifying Synergistic Effects of Sonochemotherapy with On-demand Boosted Drug Release During SDT Process.
Wu P; Dong W; Guo X; Qiao X; Guo S; Zhang L; Wan M; Zong Y
Adv Healthc Mater; 2019 Sep; 8(18):e1900720. PubMed ID: 31407517
[TBL] [Abstract][Full Text] [Related]
5. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
He H; Du L; Xue H; Wu J; Shuai X
Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069
[TBL] [Abstract][Full Text] [Related]
6. Erythrocyte-Camouflaged Mesoporous Titanium Dioxide Nanoplatform for an Ultrasound-Mediated Sequential Therapies of Breast Cancer.
Li Q; Lin B; Li Y; Lu N
Int J Nanomedicine; 2021; 16():3875-3887. PubMed ID: 34135582
[TBL] [Abstract][Full Text] [Related]
7. Cancer cell membrane-coated C-TiO
Ning S; Dai X; Tang W; Guo Q; Lyu M; Zhu D; Zhang W; Qian H; Yao X; Wang X
Acta Biomater; 2022 Oct; 152():562-574. PubMed ID: 36067874
[TBL] [Abstract][Full Text] [Related]
8. MOF-Derived Double-Layer Hollow Nanoparticles with Oxygen Generation Ability for Multimodal Imaging-Guided Sonodynamic Therapy.
Pan X; Wang W; Huang Z; Liu S; Guo J; Zhang F; Yuan H; Li X; Liu F; Liu H
Angew Chem Int Ed Engl; 2020 Aug; 59(32):13557-13561. PubMed ID: 32374941
[TBL] [Abstract][Full Text] [Related]
9. Metal-Organic Framework (MOF)-Based Ultrasound-Responsive Dual-Sonosensitizer Nanoplatform for Hypoxic Cancer Therapy.
Zhang C; Xin L; Li J; Cao J; Sun Y; Wang X; Luo J; Zeng Y; Li Q; Zhang Y; Zhang T; Huang P
Adv Healthc Mater; 2022 Jan; 11(2):e2101946. PubMed ID: 34706160
[TBL] [Abstract][Full Text] [Related]
10. A hypoxia responsive nanoassembly for tumor specific oxygenation and enhanced sonodynamic therapy.
Yang K; Yue L; Yu G; Rao L; Tian R; Wei J; Yang Z; Sun C; Zhang X; Xu M; Yuan Z; Chen X; Wang R
Biomaterials; 2021 Aug; 275():120822. PubMed ID: 34062419
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Tumor Hypoxia by pH-Responsive Liposomes to Inhibit Mitochondrial Respiration for Enhancing Sonodynamic Therapy.
Zhang N; Tan Y; Yan L; Zhang C; Xu M; Guo H; Zhuang B; Zhou L; Xie X
Int J Nanomedicine; 2020; 15():5687-5700. PubMed ID: 32821097
[TBL] [Abstract][Full Text] [Related]
12. Photosynthetic Oxygenation-Augmented Sonodynamic Nanotherapy of Hypoxic Tumors.
Lu S; Feng W; Dong C; Song X; Gao X; Guo J; Chen Y; Hu Z
Adv Healthc Mater; 2022 Feb; 11(3):e2102135. PubMed ID: 34787379
[TBL] [Abstract][Full Text] [Related]
13. Manganese porphyrin-based metal-organic framework for synergistic sonodynamic therapy and ferroptosis in hypoxic tumors.
Xu Q; Zhan G; Zhang Z; Yong T; Yang X; Gan L
Theranostics; 2021; 11(4):1937-1952. PubMed ID: 33408790
[TBL] [Abstract][Full Text] [Related]
14. Endogenous H
Du JR; Teng DK; Wang Y; Wang Q; Lin YQ; Luo Q; Xue JN; Zhu LY; Dong P; Zhang GM; Liu Y; Sun ZX; Wang H; Sui GQ
Int J Nanomedicine; 2023; 18():6667-6687. PubMed ID: 38026520
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-alleviated nanoplatform to enhance chemosensitivity and sonodynamic effect in pancreatic cancer.
Chen J; Bao Y; Song Y; Zhang C; Qiu F; Sun Y; Xin L; Cao J; Jiang Y; Luo J; Zhang C; Wang G; Li Q; Liu Y; Tong W; Huang P
Cancer Lett; 2021 Nov; 520():100-108. PubMed ID: 34245853
[TBL] [Abstract][Full Text] [Related]
16. Tablet-like TiO
Cao J; Sun Y; Zhang C; Wang X; Zeng Y; Zhang T; Huang P
Acta Biomater; 2021 Jul; 129():269-279. PubMed ID: 34082101
[TBL] [Abstract][Full Text] [Related]
17. Reactive oxygen species responsive nanoprodrug to treat intracranial glioblastoma.
Lee BS; Amano T; Wang HQ; Pantoja JL; Yoon CW; Hanson CJ; Amatya R; Yen A; Black KL; Yu JS
ACS Nano; 2013 Apr; 7(4):3061-77. PubMed ID: 23557138
[TBL] [Abstract][Full Text] [Related]
18. Strategies to Reverse Hypoxic Tumor Microenvironment for Enhanced Sonodynamic Therapy.
Li J; Yue Z; Tang M; Wang W; Sun Y; Sun T; Chen C
Adv Healthc Mater; 2024 Jan; 13(1):e2302028. PubMed ID: 37672732
[TBL] [Abstract][Full Text] [Related]
19. Boosting the sonodynamic performance of CoBiMn-layered double hydroxide nanoparticles via tumor microenvironment regulation for ultrasound imaging-guided sonodynamic therapy.
Yang S; Hu T; Williams GR; Yang Y; Zhang S; Shen J; Chen M; Liang R; Lyu L
J Nanobiotechnology; 2024 Jun; 22(1):317. PubMed ID: 38849886
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria-targeted and ultrasound-responsive nanoparticles for oxygen and nitric oxide codelivery to reverse immunosuppression and enhance sonodynamic therapy for immune activation.
Ji C; Si J; Xu Y; Zhang W; Yang Y; He X; Xu H; Mou X; Ren H; Guo H
Theranostics; 2021; 11(17):8587-8604. PubMed ID: 34373760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
